KLAS Hologic Hologic Selenia Dimensions 3D Breast Tomosynthesis Best In Award

September 11, 2014 — Hologic Inc. announced that its 3-D mammography system (Hologic Selenia Dimensions 3D Breast Tomosynthesis) was named "Best in KLAS" in the digital mammography category based on the results of an annual independent survey of healthcare executives and clinicians by KLAS Research. The "2014 Best in KLAS: Medical Equipment and Infrastructure" report examined more than 100 products in 23 different medical equipment and infrastructure categories. Hologic 3-D Mammography received the highest performance rating, a 95.2 on a scale of 1 to 100, of all the products evaluated in all 23 categories. Hologic's 2-D mammography system placed second in the digital mammography category.

It is the third consecutive year that Hologic 3-D and 2-D digital mammography systems have held the first and second place rankings, and the fifth year in a row that a Hologic mammography product has held first place in the digital mammography category. Hologic's 3-D mammography system consistently outperformed the digital mammography market segment average in the five key performance measures used to evaluate systems in this category: sales and contracting; implementation and training; functionality and upgrades; service and support; and general.

Earlier this year, KLAS issued a special report, "Breast Imaging 2014: Finding a Partner for the Future." One of the focuses of the report was which mammography product, as well as which vendor, breast-imaging sites would choose if they were making the decision to purchase today. The report named Hologic the top choice for a mammography product and vendor partner because of the company's technology leadership in both 3-D and 2-D mammography. Moreover, 100 percent of the Hologic customers interviewed stated they would choose to partner with the Company again for their digital mammography needs.

Hologic 3-D mammography was the first U.S. Food and Drug Administration FDA approved 3-D mammography system in the United States. This technology was approved for breast cancer screening and diagnosis in the United States in February, 2011 and has been available in countries recognizing the CE mark since 2008. Hologic 3-D mammography technology is in use in all 50 states and more than 50 countries.

In the United States, an estimated 6 million women will be screened with the Hologic 3-D technology in 2014. Hologic has more than 1,100 3-D mammography systems installed in the U.S.

For more information: www.3Dmammography.com


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
Subscribe Now